The French Minister of Health says the country will continue to administer the AstraZeneca Covid-19 jab, which is also arriving in Monaco at the end of the month, in spite of blood clot worries.
Olivier Veran revealed that his government will continue to administer the AstraZeneca vaccine after discussing with medical authorities the possible risks involved with the jab. Denmark, Iceland, Italy, Norway and Thailand have suspended use of the vaccine after worries arose about an increased risk of blood-clotting.
The EU’s medical regulators have reiterated there is no indication the jab is linked to a higher risk of clots than in the general population, with a mere 30 cases of “thromboembolic events” evolving out of five million doses given.
“There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine,” the European Medicines Agency (EMA) announced Thursday, adding that, “The vaccine’s benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing.”
France’s health authorities have agreed with the EMA and will continue to use the vaccine in their arsenal to fight against the pandemic, which is raging in the country at the moment in hotspots like Paris and Nice, as well as to try to prevent a third lockdown.
Veran has described France’s position as “tense and worrying” during a press conference on Thursday and stated that the country must remain vigilant in the face of high infection rates and overwhelming hospitalisations.
As previously reported in Monaco Life, the Principality will be receiving their first 7,200 doses of the Astra Zeneca vaccine in late March, adding to shipments from BioNTech-Pfizer and Moderna.
Monaco has inoculated 22% of the population so far, primarily the elderly, vulnerable and front line health care workers, and has decided to give these high-risk groups both jabs before moving on to the general population.
Day: 12 March 2021
Restrictions eased for some international travel
France is now easing some travel restrictions on travellers from outside Europe including those coming from the UK, Australia, Israel, Japan, New Zealand, Singapore and South Korea.
French Foreign Minister Jean-Baptiste Lemoyne announced the move on Thursday, saying that passengers coming to or from these seven nations will no longer need to prove a “compelling reason” for travel, such as urgent family matters or medical emergencies. He cited improving health conditions as the reason to lift the requirement.
“The list includes Britain, because the UK variant now also circulates widely in France,” he said on Twitter.
Other rules, such as the requirement for a negative Covid test less than 72 hours before travel will remain.
The list of justifiable reasons for travel for other non-European travellers has also been expanded, primarily if they involve family situations. One example is if one person in a couple, either married or in a civil partnership, is living abroad for work.
It will also include families living outside France and whose children are being schooled in the country, as well as couples with children abroad, students who are taking exams in France, and those whose principal residence is in France.
The ministry reiterated that this does not mean people should run out and start booking tickets. International travel is still strongly discouraged until the health situation is under control.
The initial reason behind the international bans in January was an attempt to keep the new variants from circulating.
Photo by Chuttersnap on Unsplash
Monaco and Israel join forces to support innovation
MonacoTech and Israeli firm Capsula TAU are collaborating to support start-ups and accelerate their development, creating business opportunities between the two countries.
Capsula TAU, an accelerator company that connects start-ups and key players in academia and business, has a focus on cleantech including green energy and emission-cutting mobility and has helped many companies make their mark, including Vayavision Sensing, Moodify and Upstream Security.
Principality-based business incubator MonacoTech and Israeli accelerator Capsula TAU, based at the Tel Aviv University, have now agreed to work together for the support of innovative start ups.
“Our collaboration is clearly business oriented to support our respective start-ups in their development,” MonacoTech Director Lionel Galfré told Monaco Life. “We are convinced at MonacoTech that innovations that matter have to be shared to be useful, and they can only be shared if they are economically viable. This collaboration with Capsula pursues that goal.”
Prince Albert, whose government funds the MonacoTech business incubator, had an online Zoom meeting last October with Tel Aviv University’s Professor Collin Price, Capsula TAU’s curator, to discuss environmental matters as well as sustainable development ideas.
“In order for us to envision a brighter future for the next generation, we have to work on climate issues together,” Prince Albert said during the meeting.
The Prince and the university have a long-standing relationship due to both entities being champions of ecological issues, with the Prince even being awarded an honorary doctorate from Tel Aviv University in 2018 for his contributions.
“Since Capsula TAU is a dominant player in the smart mobility start-up ecosystem in Israel, it will become a bridge to the Monaco ecosystem – and together we are aiming for a fruitful collaboration,” said Julia Shteingart, Managing Director of Capsula. “We are sure that the ability to share knowledge and host MonacoTech’s start-ups in Capsula and vice versa will expose both the Israeli and the Monegasque start-ups to valuable opportunities in terms of market reach and fundraising.”
Related stories:
Interview: Tel Aviv-Yafo Municipality CIO Rinat Guy
Photo of Tel Aviv sky scrapers, source Pixabay